The impact of salsalate treatment on serum levels of advanced glycation end products in type 2 diabetes.
about
Is the risk of cardiovascular disease altered with anti-inflammatory therapies? Insights from rheumatoid arthritisObesity: An Immunometabolic PerspectiveAnti-inflammatory agents to treat or prevent type 2 diabetes, metabolic syndrome and cardiovascular disease.Salsalate (Salicylate) Uncouples Mitochondria, Improves Glucose Homeostasis, and Reduces Liver Lipids Independent of AMPK-β1Anti-inflammatory Strategies to Prevent Diabetic Cardiovascular Disease.Salsalate Activates Skeletal Muscle Thermogenesis and Protects Mice from High-Fat Diet Induced Metabolic DysfunctionRegulation of metabolism by the innate immune system.Targeting adipose tissue in the treatment of obesity-associated diabetes.Methylglyoxal in Metabolic Disorders: Facts, Myths, and Promises.Preventive Effect of Salicylate and Pyridoxamine on Diabetic Nephropathy.Methylglyoxal and carboxyethyllysine reduce glutamate uptake and S100B secretion in the hippocampus independently of RAGE activation.Potential Effects of Nonsteroidal Anti-Inflammatory Drugs in the Prevention and Treatment of Type 2 Diabetes Mellitus.
P2860
Q26746659-00A7464B-3C4F-42EF-BBBE-28E4E43BEAE1Q28072140-377F25C7-D5E3-4330-B190-3F148C6FBC0BQ34444895-4D72CF8B-7A28-4F8E-9DD3-E90DEFEB4881Q37583677-703C323F-F45B-4545-97E2-AF8E44201D56Q38366821-51C5AC0E-FC8C-4FBF-8603-6B724BB6349BQ38628349-B4EF0000-A45F-4731-9206-7810F3FD64BDQ38629225-DADDBBC0-2DE2-4E10-ABD5-1EA5BF87A3DCQ38852204-C82DC51B-AAE0-4B66-A29B-5F2F53B78A00Q38956425-89FC3E55-0343-4A95-80F2-CE0CF7E79D2EQ42157259-2D294FE3-21DD-4512-A7B9-220307D044AAQ46673072-59E42655-BDFB-447E-8C0C-33AC81A9DCE2Q53785378-6782240C-BEC0-4A72-8FEE-29849CF58F50
P2860
The impact of salsalate treatment on serum levels of advanced glycation end products in type 2 diabetes.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
The impact of salsalate treatm ...... d products in type 2 diabetes.
@en
The impact of salsalate treatm ...... d products in type 2 diabetes.
@nl
type
label
The impact of salsalate treatm ...... d products in type 2 diabetes.
@en
The impact of salsalate treatm ...... d products in type 2 diabetes.
@nl
prefLabel
The impact of salsalate treatm ...... d products in type 2 diabetes.
@en
The impact of salsalate treatm ...... d products in type 2 diabetes.
@nl
P2093
P2860
P356
P1433
P1476
The impact of salsalate treatm ...... d products in type 2 diabetes.
@en
P2093
Allison B Goldfine
Christopher Strauch
Joshua I Barzilay
Kathleen A Jablonski
Steven E Shoelson
TINSAL-T2D Research Consortium
Vincent M Monnier
Vivian Fonseca
P2860
P304
P356
10.2337/DC13-1527
P407
P577
2013-11-19T00:00:00Z